期刊文献+

颞骨胆脂瘤和鳞状细胞癌细胞增殖凋亡的研究 被引量:2

Proliferation and apoptosis in cholesteatoma and squamous cell carcinoma of temporal bone
原文传递
导出
摘要 目的观察不同生长方式的颞骨胆脂瘤上皮和鳞状细胞癌细胞的增殖、凋亡特性,探讨胆脂瘤的发生发展规律。方法于颞骨手术中收集侵袭性胆脂瘤37例和非侵袭性胆脂瘤25 例,鳞状细胞癌8例,颞骨鳞状细胞癌病灶中胆脂瘤上皮5例,正常颞骨皮肤组织8例,分别采用免疫组织化学SP染色技术及末端转移酶介导的原位缺口末端标记染色(TUNEL)技术检测颞骨胆脂瘤上皮及颞骨鳞状细胞癌组织的细胞增殖和凋亡。结果各种类型胆脂瘤上皮细胞增殖指数 (MI)均显著低于颞骨鳞状细胞癌而高于正常表皮;凋亡指数(AI)显著高于正常表皮及颗骨鳞状细胞癌;增殖、凋亡指数比(MI/AI)显著高于颞骨鳞状细胞癌细胞,而与正常表皮差异无统计学意义 (P>0.05)。不同类型胆脂瘤上皮的增殖凋亡指数及增殖凋亡指数相比差异无统计学意义(P> 0.05)。结论颞骨胆脂瘤上皮细胞的生物学特性与颞骨鳞状细胞癌有显著区别,颞骨胆脂瘤上皮细胞的过度增殖和凋亡起着互相调控的作用,但同时也导致了胆脂瘤体积的增大及病变的发展。 Objective To indentify and characterize cell proliferation and apoptosis in cholesteatoma with different aggressive approaches and squamous cell carcinoma (SCC) of temporal bone and explore the role of cell proliferation and apoptosis in cholesteatoma development. Methods In 37 cases of aggressive cholesteatoma, 25 cases of non-aggressive cholesteatoma, 5 cases of SCC of temporal bone and 8 cases of normal temporal skin tissues, by using immunohistochemistry and TUNEL, cell proliferation and apoptosis were measured respectively. Results The mitosis indexs (MI) of different kinds of cholesteatomas were higher than normal skin, and lower than SCC of middle ear. By contrast, the apoptosis index (AI) of cholesteatoma epithelium was higer than the other two epithelial tissues. There was a similar MI/AI ratio in cholesteatoma and normal meatal skin epithlium. Conclusion The cell biological characteristics of cholesteatoma epithelium aredifferent to those of SCC of middle ear. The hyperproliferation of epithelium in cholesteatoma is countered by an increased apoptosis rate while in SCC of middle ear the increased cell proliferation without a compensatory increase of apoptosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第5期627-629,共3页 Chinese Journal of Experimental Surgery
基金 湖北省科技攻关计划资助项目(2002AA301C56)
关键词 胆脂瘤 颞骨鳞状细胞癌 增生 脱噬作用 Cholesteatoma Squarnous cell carcinoma Hyperplasia Apoptosis
  • 相关文献

参考文献13

  • 1Stell P, McCormick MS. Carcinoma of the middle ear: prognostic factors and a suggested staging system.J Laryngol Otol, 1985, 99:847-850.
  • 2Mallet Y, Nouwen J, Lecoete-Houcke M, et al. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1. Laryngoscope, 2003, 113 : 328-331.
  • 3Hassmann-Poznanska E, Skotnicka B, Dzieciol J. Markers of epidermal proliferation in middle ear cholesteatoma. Otolaryngol Pol, 2003, 57:505-511.
  • 4Kojima H, Tanaka Y, Tmamka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg, 1998, 124 : 261-264.
  • 5Apoptosis in normal epithelium, premalignant lesion of the oropharynx and oral cavity: a preliminary study. Oral Oncol Eur J Cancer, 2003,380-383.
  • 6Ergun S, Larlsoo B, Zheng X. Apoptosis in mental skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol, 1999, 24:280.
  • 7Holly A, Sittinger M, Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol, 1995, 252: 366-369.
  • 8Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope, 1995, 105:1232-1237.
  • 9许昱,金康业,董卫国.Ras蛋白在中耳胆脂瘤上皮中的表达[J].中华耳鼻咽喉科杂志,1999,34(2):74-76. 被引量:3
  • 10Sakamoto T, Kondo K, Yamasoba T, et al. Overexpression of ErbB-2 protein in human middle ear cholesteatomas. Laryngoscope, 2004,114 :1988-1991.

二级参考文献3

  • 1[1]Parisier S C,Agresti C J,Schwartz G K,et al.Alteration in cholesteatoma fibroblasts:Induction of neoplastic-like phenotype.Am J Otol, 1993,14:126-130.
  • 2[2]Desloge R B,Carew J F,Finstad J F,et al.DNA analysis of human cholesteatomas. Am J Otol,1997,18:155-159.
  • 3曹文庆,中华皮肤科杂志,1996年,29卷,85页

共引文献9

同被引文献16

  • 1卜仁戈,孔垂泽,吴斌,宋永胜,戴显伟.Genistein对酸性成纤维细胞生长因子诱导的EJ细胞增殖的抑制作用[J].中华实验外科杂志,2005,22(6):716-718. 被引量:4
  • 2徐泱,孙惠川,钦伦秀,刘银坤,樊嘉,汤钊猷.绿色荧光高/低转移人肝癌细胞株MHCC97-HG/LG的建立及鉴定[J].中华实验外科杂志,2006,23(5):531-533. 被引量:3
  • 3朱松柏,吕永曼.金雀异黄素抗癌作用分子机制研究进展[J].华中医学杂志,2006,30(3):253-254. 被引量:11
  • 4Makino E, Sakaguchi M, Iwatsuki K,et al. Introduction of an N-termi-nal peptide of S100C/A11 into human cells induces apoptotic celldeath[J]. J Mol Med (Berl) ,2004,82(9) :612-620.
  • 5Eberhardt NL, Grebe SK, Mclver B, et al. The role of the PAX8/PPAR-y fusion oncogene in the pathogenesis of follicular thyroid canc-er[ J]. Mol Cell Endocrinol,2010,321 (1) :50-56.
  • 6Oler G, Camacho CP, Hojaij FC,et al. Gene expression profiling ofpapillary thyroid carcinoma identifies transcripts correlated with BRAFmutational status and lymph node metastasis [ J]. Clin Cancer Res,2008,14(15) :4735 4742.
  • 7Palona I, Namba H, Mitsutake N,et al. BRAFV600E promotes inva-siveness of thyroid cancer cells through nuclear factor kB activation[J]. Endocrinology ,2006,147( 12) :5699-5707.
  • 8Chen PS,Wang MY,Wu SN,et al. CTGF enhances the motility ofbreast cancer cells via an integrin-alphavbeta3-ERKl/2-dependentSI00A4-upregulated pathway [ J ]. J Cell Sci, 2007,120 ( Pi 12 ):2053-2065.
  • 9Maddux NR,Joshi SB,Volkin DB,et al. Multidimensional methods forthe formulation of biopharmaceuticals and vaccines [ J ]. J Pharm Sci,2011,100(10):41714197.
  • 10Dubey VK,Lee J,Somasundaram T,et al. Spackling the crack:stabili-zing human fibroblast growth factor-1 by targeting the N and C termi-nus beta-strand interactions[ J]. J Mol Biol ,2007 ,371 ( 1 ) :256-268.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部